Stock analysts at StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a note issued to investors on Wednesday. The firm set a “hold” rating on the software maker’s stock.
Several other research firms have also recently issued reports on MDRX. Barclays initiated coverage on Veradigm in a research note on Wednesday, January 3rd. They set an “equal weight” rating and a $11.00 target price for the company. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $10.00 price objective (down from $15.00) on shares of Veradigm in a report on Tuesday, March 19th. Finally, Royal Bank of Canada decreased their target price on shares of Veradigm from $22.00 to $11.00 and set an “outperform” rating on the stock in a research report on Friday, January 19th. Five research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, Veradigm currently has an average rating of “Hold” and an average target price of $11.25.
View Our Latest Stock Report on MDRX
Veradigm Trading Up 0.1 %
Hedge Funds Weigh In On Veradigm
Several hedge funds have recently bought and sold shares of MDRX. TFO Wealth Partners LLC boosted its stake in shares of Veradigm by 105,280.0% in the fourth quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock valued at $52,000 after purchasing an additional 5,264 shares during the period. Gladius Capital Management LP boosted its position in Veradigm by 135.0% in the 4th quarter. Gladius Capital Management LP now owns 6,245 shares of the software maker’s stock valued at $66,000 after buying an additional 3,587 shares during the period. Meadow Creek Wealth Advisors LLC acquired a new position in shares of Veradigm in the first quarter worth $83,000. Headlands Technologies LLC grew its stake in shares of Veradigm by 14,907.7% in the fourth quarter. Headlands Technologies LLC now owns 9,755 shares of the software maker’s stock worth $102,000 after acquiring an additional 9,690 shares in the last quarter. Finally, Covestor Ltd increased its position in shares of Veradigm by 10.3% during the third quarter. Covestor Ltd now owns 10,336 shares of the software maker’s stock worth $136,000 after acquiring an additional 966 shares during the period.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- What is the Dow Jones Industrial Average (DJIA)?
- Hilton Demonstrates Asset Light is Right for Investors
- What Are Growth Stocks and Investing in Them
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.